Claruvis Secures China Approval for Retoxin®, the World’s First Recombinant Botulinum Toxin Type A

Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin&...

May 01, 2026 | Friday | News
Taiho Oncology, Inc. Advances First ADC Candidate ARC-02 into Phase 1 Following U.S. Food and Drug Administration IND Clearance

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administra...

April 30, 2026 | Thursday | News
Samsung Bioepis and ATLATL Innovation Center Sign MoU to Advance Open Innovation in Asia-Pacific Biotech

Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and de...

April 30, 2026 | Thursday | News
Illumia Expands India Footprint with New Chennai Global Capability Center

-Illumia, formerly known as Transact + CBORD, an award-winning leader in innovative higher education, healthcare, senior living, and corporate technology...

April 30, 2026 | Thursday | News
Sun Pharmaceutical Industries Limited to Acquire Organon & Co. in $11.75 Billion Deal to Expand Global Women’s Health and Biosimilars Footprint

Sun Pharmaceutical Industries Limitedand Organon & Co. announced that they have entered into a definitive agreement under which Sun Pharma will acqui...

April 29, 2026 | Wednesday | News
Dark Horse Consulting Group and Porton Advanced Forge Strategic Alliance to Accelerate Global Cell and Gene Therapy Development

Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, and Porton...

April 28, 2026 | Tuesday | News
WuXi Biologics Secures South Korea MFDS GMP Certification for Three Wuxi Facilities

 WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manu...

April 24, 2026 | Friday | News
John Rim Highlights Stable Q1 2026 Growth as Samsung Biologics Expands Manufacturing Capacity

"In the first quarter, Samsung Biologics delivered stable growth, supported by consistent execution across our manufacturing network and continued demand f...

April 23, 2026 | Thursday | Company results
Andelyn Biosciences and ENCell Co., Ltd. Forge Strategic Alliance to Accelerate Global Gene Therapy Manufacturing

Andelyn Biosciences, (“Andelyn”) a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...

April 23, 2026 | Thursday | News
Astellas and Pfizer Secure FDA Priority Review for PADCEV–Keytruda in Muscle-Invasive Bladder Cancer

  Submission based on statistically significant event-free and overall survival data from the Phase 3 EV-304 trial Building on the existing indica...

April 22, 2026 | Wednesday | News
Nxera Pharma Secures Third R&D Milestone in Neurology Collaboration with AbbVie

This marks the third milestone achieved under the collaboration and reflects the steady progress of the pipeline Under the terms of the agreement, Nxe...

April 21, 2026 | Tuesday | News
Repligen Opens New Training & Innovation Center in the Netherlands to Strengthen Global Bioprocessing Support

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new ...

April 20, 2026 | Monday | News
Novo Nordisk Partners with OpenAI to Lead AI-Driven Transformation Across Drug Discovery and Operations

Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare ...

April 15, 2026 | Wednesday | News
Neurocrine Advances Nxera-Discovered NBI-1117570 into Phase 2 for Schizophrenia

NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical development und...

April 14, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close